DMT210 Topical Gel in the Treatment of Atopic Dermatitis
Status:
Completed
Trial end date:
2017-07-14
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the safety and efficacy of DMT210 Gel, 5% compared
to vehicle control following 28 days of twice-daily topical application to selected target
lesions in male and female patients with mild to moderate atopic dermatitis (AD).